Robeco Institutional Asset Management B.V. Sells 40,873 Shares of Xylem Inc. (XYL)
Robeco Institutional Asset Management B.V. reduced its position in shares of Xylem Inc. (NYSE:XYL) by 11.7% during the third quarter, Holdings Channel reports. The institutional investor owned 309,681 shares of the company’s stock after selling 40,873 shares during the period. Robeco Institutional Asset Management B.V.’s holdings in Xylem were worth $16,243,000 as of its most recent filing with the SEC.
Several other institutional investors have also recently added to or reduced their stakes in the stock. Vanguard Group Inc. raised its position in Xylem by 2.7% in the second quarter. Vanguard Group Inc. now owns 15,709,412 shares of the company’s stock worth $701,425,000 after buying an additional 406,831 shares in the last quarter. FMR LLC raised its position in Xylem by 74.1% in the second quarter. FMR LLC now owns 5,956,085 shares of the company’s stock worth $265,940,000 after buying an additional 2,534,911 shares in the last quarter. BlackRock Fund Advisors raised its position in Xylem by 5.2% in the second quarter. BlackRock Fund Advisors now owns 2,953,751 shares of the company’s stock worth $131,885,000 after buying an additional 147,067 shares in the last quarter. Impax Asset Management LTD raised its position in Xylem by 2.4% in the second quarter. Impax Asset Management LTD now owns 2,295,661 shares of the company’s stock worth $102,502,000 after buying an additional 52,972 shares in the last quarter. Finally, Ameriprise Financial Inc. raised its position in Xylem by 0.6% in the second quarter. Ameriprise Financial Inc. now owns 1,989,620 shares of the company’s stock worth $88,835,000 after buying an additional 12,129 shares in the last quarter. 86.38% of the stock is currently owned by institutional investors.
Shares of Xylem Inc. (NYSE:XYL) traded up 1.21% during midday trading on Wednesday, hitting $51.96. 543,254 shares of the stock traded hands. Xylem Inc. has a 1-year low of $31.67 and a 1-year high of $54.99. The stock has a 50 day moving average of $50.32 and a 200 day moving average of $48.42. The company has a market capitalization of $9.32 billion, a P/E ratio of 28.83 and a beta of 1.18.
Xylem (NYSE:XYL) last announced its earnings results on Tuesday, November 1st. The company reported $0.54 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.53 by $0.01. Xylem had a net margin of 8.83% and a return on equity of 16.38%. The business had revenue of $897 million for the quarter, compared to analyst estimates of $913.53 million. During the same quarter in the previous year, the firm posted $0.49 earnings per share. Xylem’s revenue was down .6% compared to the same quarter last year. Equities research analysts predict that Xylem Inc. will post $2.04 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Wednesday, December 7th. Investors of record on Wednesday, November 9th will be given a dividend of $0.1549 per share. This represents a $0.62 dividend on an annualized basis and a yield of 1.21%. The ex-dividend date is Monday, November 7th. Xylem’s dividend payout ratio (DPR) is currently 34.44%.
A number of equities analysts have recently commented on XYL shares. Atlantic Securities raised shares of Xylem from a “neutral” rating to an “overweight” rating and set a $54.00 price target on the stock in a research report on Monday, August 22nd. Canaccord Genuity reaffirmed a “hold” rating and set a $50.00 target price (up previously from $45.00) on shares of Xylem in a research report on Tuesday, August 16th. Royal Bank Of Canada boosted their target price on shares of Xylem from $47.00 to $51.00 and gave the stock an “outperform” rating in a research report on Tuesday, August 16th. Oppenheimer Holdings Inc. reaffirmed an “outperform” rating and set a $58.00 target price (up previously from $55.00) on shares of Xylem in a research report on Monday, November 21st. Finally, Stifel Nicolaus boosted their target price on shares of Xylem from $47.00 to $48.00 and gave the stock a “hold” rating in a research report on Wednesday, November 2nd. Eight investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. Xylem has an average rating of “Buy” and an average price target of $47.15.
In other Xylem news, insider Colin R. Sabol sold 27,473 shares of Xylem stock in a transaction on Thursday, September 8th. The shares were sold at an average price of $50.91, for a total transaction of $1,398,650.43. Following the sale, the insider now owns 65,530 shares in the company, valued at $3,336,132.30. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Claudia S. Toussaint sold 5,300 shares of Xylem stock in a transaction on Friday, November 4th. The stock was sold at an average price of $47.27, for a total transaction of $250,531.00. Following the sale, the senior vice president now owns 44,033 shares in the company, valued at approximately $2,081,439.91. The disclosure for this sale can be found here. Corporate insiders own 0.77% of the company’s stock.
Xylem Company Profile
Xylem Inc is engaged in the design, manufacturing, and application of engineered technologies for the water industry. The Company is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL).
Receive News & Ratings for Xylem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem Inc. and related companies with MarketBeat.com's FREE daily email newsletter.